Skip to main content
Top
Published in: Journal of Orthopaedic Surgery and Research 1/2017

Open Access 01-12-2017 | Research article

In vivo evaluation of microglia activation by intracranial iron overload in central pain after spinal cord injury

Authors: Fan Xing Meng, Jing Ming Hou, Tian Sheng Sun

Published in: Journal of Orthopaedic Surgery and Research | Issue 1/2017

Login to get access

Abstract

Background

Central pain (CP) is a common clinical problem in patients with spinal cord injury (SCI). Recent studies found the pathogenesis of CP was related to the remodeling of the brain. We investigate the roles of iron overload and subsequent microglia activate in the remodeling of the brain after SCI.

Methods

An SCI-induced CP model was established in Sprague-Dawley rats that were randomly assigned to SCI, sham operation, deferoxamine (DFX), minocycline, and nitric oxide synthase inhibitor treatment groups. At 12 weeks, pain behavior and thermal pain threshold were evaluated in each group, and iron transferrin receptor (TfR)1 and ferritin (Fn) mRNA, as well as iron-regulatory protein (IRP)1, FN, lactoferrin, and nuclear factor (NF)-κB protein levels in the rat brains were measured. Microglia proliferation and differentiation and IRP1 expression were evaluated by immunohistochemistry.

Results

Autophagy was observed in rats after SCI, accompanied by reduced latency of thermal pain, increased iron content and IRP1 and NF-κB levels in the hindlimb sensory area, hippocampus, and thalamus, and decreased Fn levels in the hindlimb sensory area. TfR1 mRNA expression was upregulated in activated microglia. Treatment with an iron-chelating agent, or inhibitors of nitric oxide synthase or microglia suppressed microglia proliferation.

Conclusions

SCI may induce intracranial iron overload, which activates microglia via NF-κB signaling. Microglia secrete inflammatory factors that induce neuronal damage and lead to CP. Treatment with an iron-chelating agent or NF-κB or microglia inhibitors can relieve CP resulting from SCI.
Literature
1.
go back to reference Bonica JJ. History of pain concepts and pain therapy. Mt Sinai J Med. 1991;58(3):191–202.PubMed Bonica JJ. History of pain concepts and pain therapy. Mt Sinai J Med. 1991;58(3):191–202.PubMed
3.
go back to reference Yezierski RP. Pain following spinal cord injury: the clinical problem and experimental studies. Pain. 1996;68(2–3):185–94. Review.CrossRefPubMed Yezierski RP. Pain following spinal cord injury: the clinical problem and experimental studies. Pain. 1996;68(2–3):185–94. Review.CrossRefPubMed
4.
go back to reference Klega A, Eberle T, Buchholz HG, et al. Central opioidergic neurotransmission in complex regional pain syndrome. Neurology. 2010;75(2):129–36.CrossRefPubMed Klega A, Eberle T, Buchholz HG, et al. Central opioidergic neurotransmission in complex regional pain syndrome. Neurology. 2010;75(2):129–36.CrossRefPubMed
5.
go back to reference Buckalew N, Haut MW, Morrow L, et al. Chronic pain is associated with brain volume loss in older adults: preliminary evidence. Pain Med. 2008;9(2):240–8.CrossRefPubMed Buckalew N, Haut MW, Morrow L, et al. Chronic pain is associated with brain volume loss in older adults: preliminary evidence. Pain Med. 2008;9(2):240–8.CrossRefPubMed
6.
go back to reference Gustin SM, Wrigley PJ, Siddall PJ, et al. Brain anatomy changes associated with persistent neuropathic pain following spinal cord injury. Cereb Cortex. 2010;20(6):1409–19.CrossRefPubMed Gustin SM, Wrigley PJ, Siddall PJ, et al. Brain anatomy changes associated with persistent neuropathic pain following spinal cord injury. Cereb Cortex. 2010;20(6):1409–19.CrossRefPubMed
7.
go back to reference Likavcanova K, Urdzikova L, Hajek M, et al. Metabolic changes in the thalamus after spinal cord injury followed by proton MR spectroscopy. Magn Reson Med. 2008;59(3):499–506.CrossRefPubMed Likavcanova K, Urdzikova L, Hajek M, et al. Metabolic changes in the thalamus after spinal cord injury followed by proton MR spectroscopy. Magn Reson Med. 2008;59(3):499–506.CrossRefPubMed
8.
go back to reference Peyron R, Schneider F, Faillenot I, et al. An fMRI study of cortical representation of mechanical allodynia in patients with neuropathic pain. Neurology. 2004;63(10):1838–46.CrossRefPubMed Peyron R, Schneider F, Faillenot I, et al. An fMRI study of cortical representation of mechanical allodynia in patients with neuropathic pain. Neurology. 2004;63(10):1838–46.CrossRefPubMed
9.
go back to reference Wrigley PJ, Press SR, Gustin SM, et al. Neuropathic pain and primary somatosensory cortex reorganization following spinal cord injury. Pain. 2009;141(1–2):52–9.CrossRefPubMed Wrigley PJ, Press SR, Gustin SM, et al. Neuropathic pain and primary somatosensory cortex reorganization following spinal cord injury. Pain. 2009;141(1–2):52–9.CrossRefPubMed
10.
go back to reference Jin L, Wang J, Zhao L, et al. Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson’s disease. Brain. 2011;134(Pt 1):50–8.CrossRefPubMed Jin L, Wang J, Zhao L, et al. Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson’s disease. Brain. 2011;134(Pt 1):50–8.CrossRefPubMed
11.
go back to reference Chen Z, Gao C, Hua Y, et al. Role of iron in brain injury after intraventricular hemorrhage. Stroke. 2011;42(2):465–70.CrossRefPubMed Chen Z, Gao C, Hua Y, et al. Role of iron in brain injury after intraventricular hemorrhage. Stroke. 2011;42(2):465–70.CrossRefPubMed
12.
go back to reference Duce JA, Tsatsanis A, Cater MA, et al. Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer’s disease. Cell. 2010;142(6):857–67.CrossRefPubMedPubMedCentral Duce JA, Tsatsanis A, Cater MA, et al. Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer’s disease. Cell. 2010;142(6):857–67.CrossRefPubMedPubMedCentral
13.
go back to reference Mairuae N, Connor JR, Cheepsunthorn P. Increased cellular iron levels affect matrix metalloproteinase expression and phagocytosis in activated microglia. Neurosci Lett. 2011;500(1):36–40.CrossRefPubMed Mairuae N, Connor JR, Cheepsunthorn P. Increased cellular iron levels affect matrix metalloproteinase expression and phagocytosis in activated microglia. Neurosci Lett. 2011;500(1):36–40.CrossRefPubMed
14.
go back to reference Chen CW, Chen QB, Ouyang Q, et al. Transient early neurotrophin release and delayed inflammatory cytokine release by microglia in response to PAR-2 stimulation. J Neuroinflammation. 2012;9:142.PubMedPubMedCentral Chen CW, Chen QB, Ouyang Q, et al. Transient early neurotrophin release and delayed inflammatory cytokine release by microglia in response to PAR-2 stimulation. J Neuroinflammation. 2012;9:142.PubMedPubMedCentral
15.
go back to reference Smith JA, Das A, Ray SK, et al. Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull. 2012;87(1):10–20.CrossRefPubMed Smith JA, Das A, Ray SK, et al. Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull. 2012;87(1):10–20.CrossRefPubMed
16.
go back to reference Kim BW, Koppula S, Hong SS, et al. Regulation of microglia activity by glaucocalyxin-A: attenuation of lipopolysaccharide-stimulated neuroinflammation through NF-κ B and p38 MAPK signaling pathways. PLoS One. 2013;8(2):e55792.CrossRefPubMedPubMedCentral Kim BW, Koppula S, Hong SS, et al. Regulation of microglia activity by glaucocalyxin-A: attenuation of lipopolysaccharide-stimulated neuroinflammation through NF-κ B and p38 MAPK signaling pathways. PLoS One. 2013;8(2):e55792.CrossRefPubMedPubMedCentral
17.
18.
20.
go back to reference Nepomuceno C, Fine PR, Richards JS, et al. Pain in patients with spinal cord injury. Arch Phys Med Rehabil. 1979;60(12):605–9.PubMed Nepomuceno C, Fine PR, Richards JS, et al. Pain in patients with spinal cord injury. Arch Phys Med Rehabil. 1979;60(12):605–9.PubMed
21.
go back to reference Attal NL, Mazaltarine G, Perrouin-Verbe B, et al. Chronic neuropathic pain management in spinal cord injury patients. What is the efficacy of pharmacological treatments with a general mode of administration? (oral, transdermal, intravenous). Ann Phys Rehabil Med. 2009;52(2):124–41.CrossRefPubMed Attal NL, Mazaltarine G, Perrouin-Verbe B, et al. Chronic neuropathic pain management in spinal cord injury patients. What is the efficacy of pharmacological treatments with a general mode of administration? (oral, transdermal, intravenous). Ann Phys Rehabil Med. 2009;52(2):124–41.CrossRefPubMed
22.
go back to reference Baastrup C, Finnerup NB. Pharmacological management of neuropathic pain following spinal cord injury. CNS Drugs. 2008;22(6):455–75.CrossRefPubMed Baastrup C, Finnerup NB. Pharmacological management of neuropathic pain following spinal cord injury. CNS Drugs. 2008;22(6):455–75.CrossRefPubMed
23.
go back to reference Miki K, Iwata K, Tsuboi Y, et al. Dorsal column-thalamic pathway is involved in thalamic hyperexcitability following peripheral nerve injury: a lesion study in rats with experimental mononeuropathy. Pain. 2000;85(1–2):263–71.CrossRefPubMed Miki K, Iwata K, Tsuboi Y, et al. Dorsal column-thalamic pathway is involved in thalamic hyperexcitability following peripheral nerve injury: a lesion study in rats with experimental mononeuropathy. Pain. 2000;85(1–2):263–71.CrossRefPubMed
24.
go back to reference Sokal DM, Chapman V. Effects of spinal administration of muscimol on C- and A-fibre evoked neuronal responses of spinal dorsal horn neurones in control and nerve injured rats. Brain Res. 2003;962(1–2):213–20.CrossRefPubMed Sokal DM, Chapman V. Effects of spinal administration of muscimol on C- and A-fibre evoked neuronal responses of spinal dorsal horn neurones in control and nerve injured rats. Brain Res. 2003;962(1–2):213–20.CrossRefPubMed
25.
go back to reference Dougherty PM, Palecek J, Paleckova V, et al. The role of NMDA and non-NMDA excitatory amino acid receptors in the excitation of primate spinothalamic tract neurons by mechanical, chemical, thermal, and electrical stimuli. Neurosci. 1992;12(8):3025–41. Dougherty PM, Palecek J, Paleckova V, et al. The role of NMDA and non-NMDA excitatory amino acid receptors in the excitation of primate spinothalamic tract neurons by mechanical, chemical, thermal, and electrical stimuli. Neurosci. 1992;12(8):3025–41.
26.
go back to reference Melzack R, Loeser JD. Phantom body pain in paraplegics: evidence for a central “pattern generating mechanism” for pain. Pain. 1978;4(3):195–210.PubMed Melzack R, Loeser JD. Phantom body pain in paraplegics: evidence for a central “pattern generating mechanism” for pain. Pain. 1978;4(3):195–210.PubMed
27.
go back to reference Evseev VA, Davydova TV, Vetrile LA. Common neuroimmunological features of drug addiction, alcoholism, epilepsy, and neurogenic pain syndromes. Vestn Ross Akad Med Nauk. 2006;(7):38–43. Evseev VA, Davydova TV, Vetrile LA. Common neuroimmunological features of drug addiction, alcoholism, epilepsy, and neurogenic pain syndromes. Vestn Ross Akad Med Nauk. 2006;(7):38–43.
28.
go back to reference Richards JS, Meredith RL, Nepomuceno C, et al. Psycho-social aspects of chronic pain in spinal cord injury. Pain. 1980;8(3):355–66.CrossRefPubMed Richards JS, Meredith RL, Nepomuceno C, et al. Psycho-social aspects of chronic pain in spinal cord injury. Pain. 1980;8(3):355–66.CrossRefPubMed
29.
go back to reference Summers JD, Rapoff MA, Varghese G, Porter K, Palmer RE. Psychosocial factors in chronic spinal cord injury pain. Pain. 1991;4:7183–9. Summers JD, Rapoff MA, Varghese G, Porter K, Palmer RE. Psychosocial factors in chronic spinal cord injury pain. Pain. 1991;4:7183–9.
30.
go back to reference Thompson FJ, Reier PJ, Lucas CC, Parmer R, et al. Altered patterns of reflex excitability subsequent to contusion injury of the rat spinal cord. J Neurophysiol. 1992;68(5):1473–86.PubMed Thompson FJ, Reier PJ, Lucas CC, Parmer R, et al. Altered patterns of reflex excitability subsequent to contusion injury of the rat spinal cord. J Neurophysiol. 1992;68(5):1473–86.PubMed
31.
go back to reference Atwood CS, Obrenovich ME, Liu T, Chan H, Perry G, Smith MA, Martins RN. Amyloid-beta: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-beta. Brain Res Brain Res Rev. 2003;43(1):1–16.CrossRefPubMed Atwood CS, Obrenovich ME, Liu T, Chan H, Perry G, Smith MA, Martins RN. Amyloid-beta: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-beta. Brain Res Brain Res Rev. 2003;43(1):1–16.CrossRefPubMed
32.
36.
go back to reference Qian ZM, Wang Q. Expression of iron transport prote in sand excessiveiron accumulation of iron in the brain in neuro degenerative disorders. Brain Res Rev. 1998;27:257–67.CrossRefPubMed Qian ZM, Wang Q. Expression of iron transport prote in sand excessiveiron accumulation of iron in the brain in neuro degenerative disorders. Brain Res Rev. 1998;27:257–67.CrossRefPubMed
37.
go back to reference Wang L, Wang W, Zhao M, Ma L, Li M. Psychological stress induces dysregulation of iron metabolism in rat brain. Neuroscience. 2008;155(1):24–30.CrossRefPubMed Wang L, Wang W, Zhao M, Ma L, Li M. Psychological stress induces dysregulation of iron metabolism in rat brain. Neuroscience. 2008;155(1):24–30.CrossRefPubMed
38.
go back to reference Berg D, Youdim MB. Role of iron in neurodegenerative disorders. Top Magn Reson Imaging. 2006;17(1):5–17.CrossRefPubMed Berg D, Youdim MB. Role of iron in neurodegenerative disorders. Top Magn Reson Imaging. 2006;17(1):5–17.CrossRefPubMed
39.
40.
go back to reference Curtis AR, Fey C, Morris CM. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet. 2001;28(4):350–4.CrossRefPubMed Curtis AR, Fey C, Morris CM. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet. 2001;28(4):350–4.CrossRefPubMed
41.
go back to reference Bradbury MW. Transport of iron in the blood-brain-cerebrospinal fluid system. Neurochem. 1997;69(2):443–54.CrossRef Bradbury MW. Transport of iron in the blood-brain-cerebrospinal fluid system. Neurochem. 1997;69(2):443–54.CrossRef
42.
go back to reference Moos T, Morgan EH. Evidence for low molecular weight, non-transferrin-bound iron in rat brain and cerebrospinal fluid. J Neurosci Res. 1998;54(4):486–94.CrossRefPubMed Moos T, Morgan EH. Evidence for low molecular weight, non-transferrin-bound iron in rat brain and cerebrospinal fluid. J Neurosci Res. 1998;54(4):486–94.CrossRefPubMed
43.
go back to reference Attieh ZK, Mukhopadhyay CK, Seshadri V. Ceruloplasmin ferroxidase activity stimulates cellular iron uptake by a trivalent cation-specific transport mechanism. J Biol Chem. 1999;274(2):1116–23.CrossRefPubMed Attieh ZK, Mukhopadhyay CK, Seshadri V. Ceruloplasmin ferroxidase activity stimulates cellular iron uptake by a trivalent cation-specific transport mechanism. J Biol Chem. 1999;274(2):1116–23.CrossRefPubMed
44.
go back to reference Hulet SW, Powers S, Connor JR. Distribution of transferrin and ferritin binding in normal and multiple sclerotic human brains. J Neurol Sci. 1999;165(1):48–55.CrossRefPubMed Hulet SW, Powers S, Connor JR. Distribution of transferrin and ferritin binding in normal and multiple sclerotic human brains. J Neurol Sci. 1999;165(1):48–55.CrossRefPubMed
45.
go back to reference Hallgren B. The effect of age on the nonhaemin iron in the human brain. J Neurochem. 1958;3:41–51.CrossRefPubMed Hallgren B. The effect of age on the nonhaemin iron in the human brain. J Neurochem. 1958;3:41–51.CrossRefPubMed
46.
go back to reference Connor JR, Snyder BS, Arosio P. A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer’s diseased brains. J Neurochem. 1995;65(2):717–24.CrossRefPubMed Connor JR, Snyder BS, Arosio P. A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer’s diseased brains. J Neurochem. 1995;65(2):717–24.CrossRefPubMed
47.
go back to reference Harrison PM, Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta. 1996;1275(3):161–203.CrossRefPubMed Harrison PM, Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta. 1996;1275(3):161–203.CrossRefPubMed
48.
go back to reference Levi S, Yewdall SJ, Harrison PM, et al. Evidence that H- and L- chains have cooperative roles in the iron-uptake mechanism of human ferritin. Bioehem J. 1992;288:591–6. Levi S, Yewdall SJ, Harrison PM, et al. Evidence that H- and L- chains have cooperative roles in the iron-uptake mechanism of human ferritin. Bioehem J. 1992;288:591–6.
50.
go back to reference Filipov NM, Seegal RF, Lawrence DA. Manganese potentiates in vitro production of proinflammatory cytokines and nitric oxide by microglia through a nuclear factor kappa B-dependent mechanism. Toxicol Sci. 2005;84(1):139–48.CrossRefPubMed Filipov NM, Seegal RF, Lawrence DA. Manganese potentiates in vitro production of proinflammatory cytokines and nitric oxide by microglia through a nuclear factor kappa B-dependent mechanism. Toxicol Sci. 2005;84(1):139–48.CrossRefPubMed
51.
go back to reference Xiong S, She H, Takeuchi H, et al. Signaling role of intracellular iron in NF-kappaB activation. J Biol Chem. 2003;278(20):17646–54.CrossRefPubMed Xiong S, She H, Takeuchi H, et al. Signaling role of intracellular iron in NF-kappaB activation. J Biol Chem. 2003;278(20):17646–54.CrossRefPubMed
52.
go back to reference Kauppinen TM, Swanson RA. Poly(ADP-ribose) polymerase-1 promotes microglial activation, proliferation, and matrix metalloproteinase-9-mediated neuron death. J Immunol. 2005;174(4):2288–96.CrossRefPubMed Kauppinen TM, Swanson RA. Poly(ADP-ribose) polymerase-1 promotes microglial activation, proliferation, and matrix metalloproteinase-9-mediated neuron death. J Immunol. 2005;174(4):2288–96.CrossRefPubMed
53.
go back to reference Klegeris A, McGeer PL. Interaction of various intracellular signaling mechanisms involved in mononuclear phagocyte toxicity toward neuronal cells. J Leukoc Biol. 2000;67(1):127–33.PubMed Klegeris A, McGeer PL. Interaction of various intracellular signaling mechanisms involved in mononuclear phagocyte toxicity toward neuronal cells. J Leukoc Biol. 2000;67(1):127–33.PubMed
54.
go back to reference Jellinger K, Paulus W, Grundke-Iqbal I, Riederer P, Youdim MB. J Neural Transm Park Dis Dement Sect. 1990;2(4):327–40.CrossRefPubMed Jellinger K, Paulus W, Grundke-Iqbal I, Riederer P, Youdim MB. J Neural Transm Park Dis Dement Sect. 1990;2(4):327–40.CrossRefPubMed
56.
go back to reference Chen H, Jacobs E, Schwarzschild MA. Nonsteroidal antiinflammatory drug use and the risk for Parkinson’s disease. Ann Neurol. 2005;58(6):963–7.CrossRefPubMed Chen H, Jacobs E, Schwarzschild MA. Nonsteroidal antiinflammatory drug use and the risk for Parkinson’s disease. Ann Neurol. 2005;58(6):963–7.CrossRefPubMed
57.
go back to reference Wang J, Tsirka SE. Tuftsin fragment 1–3 is beneficial when delivered after the induction of intracerebral hemorrhage. Stroke. 2005;36(3):613–8. Epub 2005 Feb 3.CrossRefPubMed Wang J, Tsirka SE. Tuftsin fragment 1–3 is beneficial when delivered after the induction of intracerebral hemorrhage. Stroke. 2005;36(3):613–8. Epub 2005 Feb 3.CrossRefPubMed
Metadata
Title
In vivo evaluation of microglia activation by intracranial iron overload in central pain after spinal cord injury
Authors
Fan Xing Meng
Jing Ming Hou
Tian Sheng Sun
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Journal of Orthopaedic Surgery and Research / Issue 1/2017
Electronic ISSN: 1749-799X
DOI
https://doi.org/10.1186/s13018-017-0578-z

Other articles of this Issue 1/2017

Journal of Orthopaedic Surgery and Research 1/2017 Go to the issue